Notice type: 3rd Party Publications
The HPRA would like to highlight a letter issued to healthcare professionals by Advanz Pharma on 15 September 2022.
The letter communicates that the product information has been further updated with recommendations for use in children. There has been a Change from ‘Contraindication’ to ‘Prescribe with Caution’ for children under 2 years.
Please download the letter using the link below. Please note that this letter supersedes previous letters issued to healthcare professionals on this product (October 2020, June 2021).
Latest communication - 15 September 2022
Product Information Update - Chloromycetin Redidrops Eye Drops (Chloramphenicol) 15 September 2022
Previous Product Information Updates on this product
Please note the two communications below are now superseded by the communication published on 15 September.